ABCL
Price
$3.03
Change
-$0.11 (-3.50%)
Updated
Feb 21 closing price
Capitalization
897.91M
5 days until earnings call
NKTX
Price
$2.05
Change
-$0.10 (-4.65%)
Updated
Feb 21 closing price
Capitalization
144.67M
26 days until earnings call
Ad is loading...

ABCL vs NKTX

Header iconABCL vs NKTX Comparison
Open Charts ABCL vs NKTXBanner chart's image
AbCellera Biologics
Price$3.03
Change-$0.11 (-3.50%)
Volume$2.37M
Capitalization897.91M
Nkarta
Price$2.05
Change-$0.10 (-4.65%)
Volume$1.97M
Capitalization144.67M
ABCL vs NKTX Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. NKTX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and NKTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (ABCL: $3.43 vs. NKTX: $2.27)
Brand notoriety: ABCL and NKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 219% vs. NKTX: 86%
Market capitalization -- ABCL: $897.91M vs. NKTX: $144.67M
ABCL [@Biotechnology] is valued at $897.91M. NKTX’s [@Biotechnology] market capitalization is $144.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileNKTX’s FA Score has 1 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • NKTX’s FA Score: 1 green, 4 red.
According to our system of comparison, ABCL is a better buy in the long-term than NKTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 6 TA indicator(s) are bullish while NKTX’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 6 bullish, 2 bearish.
  • NKTX’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than NKTX.

Price Growth

ABCL (@Biotechnology) experienced а +16.27% price change this week, while NKTX (@Biotechnology) price change was +11.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.27%. For the same industry, the average monthly price growth was +3.99%, and the average quarterly price growth was +2.35%.

Reported Earning Dates

ABCL is expected to report earnings on May 13, 2025.

NKTX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+4.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($898M) has a higher market cap than NKTX($145M). ABCL YTD gains are higher at: 17.065 vs. NKTX (-8.835). NKTX has higher annual earnings (EBITDA): -119.34M vs. ABCL (-202.4M). ABCL has more cash in the bank: 643M vs. NKTX (283M). ABCL has less debt than NKTX: ABCL (71.4M) vs NKTX (85.4M). ABCL has higher revenues than NKTX: ABCL (33M) vs NKTX (0).
ABCLNKTXABCL / NKTX
Capitalization898M145M619%
EBITDA-202.4M-119.34M170%
Gain YTD17.065-8.835-193%
P/E RatioN/AN/A-
Revenue33M0-
Total Cash643M283M227%
Total Debt71.4M85.4M84%
TECHNICAL ANALYSIS
Technical Analysis
ABCLNKTX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 5 days ago
85%
Momentum
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 5 days ago
85%
MACD
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 5 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
75%
Bullish Trend 5 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 5 days ago
86%
Declines
ODDS (%)
Bearish Trend 12 days ago
85%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 5 days ago
75%
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Ad is loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with NTLA. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+4.89%
NTLA - ABCL
55%
Loosely correlated
+7.76%
BEAM - ABCL
54%
Loosely correlated
+3.36%
CRSP - ABCL
54%
Loosely correlated
+5.03%
ADPT - ABCL
54%
Loosely correlated
-0.72%
PRME - ABCL
53%
Loosely correlated
+5.28%
More

NKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with FATE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
+2.71%
FATE - NKTX
54%
Loosely correlated
+7.75%
IPSC - NKTX
49%
Loosely correlated
-0.81%
ALLO - NKTX
47%
Loosely correlated
+39.22%
PRME - NKTX
46%
Loosely correlated
+5.28%
ABCL - NKTX
45%
Loosely correlated
+4.89%
More